The latest news in cancer research, health and policy by Cancer Research UK.
We cover developments in cancer treatments, research into cancer risk and diagnosis as well as the latest cancer science stories. You'll also find analysis and comment on health and cancer policy.
Scientists from the University of Glasgow are developing new ways to predict who will respond to drugs targeting damaged DNA in pancreatic cancer.
The National Lung Matrix Trial - a £25 million collaboration with pharmaceutical companies and the NHS - has been exploring how patients with non small cell lung cancer...
Cancer Research UK’s calls backed by eminent Edinburgh scientist who says the COVID-19 halt to clinical trials has taken away hope for some patients.
New clinical trial results show that adding rituximab to standard chemotherapy could improve survival for some children with non-Hodgkin lymphoma.
Through our new research strategy, we're determined to improve survival and reduce long-term side effects for children and young people with cancer.
NHS England announced plans to fast track “revolutionary” new cancer drugs. But there’s still some way to go before these drugs might reach patients.
A dual kinase inhibitor is entering a clinical trial for advanced pancreatic cancer in combination with gemcitabine.
A drug that’s designed to target weaknesses inside cancer cells can hold some advanced pancreatic cancers at bay for a short time after chemotherapy.
An immunotherapy drug could prove just as effective as chemotherapy in prolonging the lives of patients with advanced cancers of the stomach or food pipe.
Combining a targeted drug with hormone therapy extended the lives of pre-menopausal women with advanced breast cancer in a clinical trial.